A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Clinical trial NCT01381900 · COMPLETED

Trial details

NCT number

NCT01381900

Sponsor

Janssen Research & Development, LLC

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2011-08-01

Primary completion

2012-11-01

Enrollment

678

View on ClinicalTrials.gov